BioCentury
ARTICLE | Clinical News

Nasulin intranasal insulin: Completed Phase IIa enrollment

January 4, 2010 8:00 AM UTC

CPEX completed enrollment of 94 patients in a double-blind, placebo-controlled, U.S. Phase IIa study to evaluate basal insulin and oral anti-diabetes agents in combination with inhaled Nasulin or plac...